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Liverpool School of Tropical Medicine, Liverpool, United Kingdomc; School of Life Sciences, University of Nottingham, Nottingham, United Kingdomd
We thank Kock et al. for highlighting their point to readers ofour paper (1).Our paper does indeed include the suggestion
that the results might have the potential for clinical application,
including in malaria patients. The use of chloroquine (CQ) as an
antifungal agent is not a new concept. Inhibition of opportunistic
fungal pathogens such as Cryptococcus neoformans and Histo-
plasma capsulatum in the presence of CQ has been shown previ-
ously, in vitro as well as in vivo (2, 3). The experiments with other
fungal pathogens described in our paper showed that the antifun-
gal action of CQ could be enhanced in organisms with compro-
mised cell walls. One logical next step would be to investigate this
particular effect in vivo, during infection.
Previous studies indicate that the mechanisms of inhibition by
CQmaydiffer between fungal species. For example,C. neoformans
was inhibited by CQ-dependent increases in phagolysosomal pH
which created an environment too alkaline for growth of this
pathogen (3). Related mechanisms of CQ action are known in the
malaria parasite (4). In the case of H. capsulatum, CQ acted by
pH-dependent iron deprivation (2), and a similarmechanismwas
suggested for the model yeast Saccharomyces cerevisiae (5). More
recently, however, thiamine transporters were found to be key
targets of CQ action in S. cerevisiae as well as in cultured human
cell lines (6). The latter mode of action may be particularly rele-
vant to the findings we reported as it relies on direct interaction
between CQ and the target organism, which should be exacer-
bated by increased CQ uptake in fungi with perturbed cell walls
(1), rather than indirectly through an effect of CQ on host envi-
ronment.
Fertility-promoting effects of CQ as described in the com-
ments of Kock et al. have yet to be reconciled with the antifungal
effects of this drug summarized above. Clearly, if clinical applica-
tion of CQ as part of an antifungal therapy is to be realized, we
agree that it is important that possible issues such as those raised in
the comments should be resolved. To that end, it will be helpful to
characterize the relative antifungal and fertility-promoting effects
of CQ across different CQ doses and in different fungi, including
in vivo.
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